Similar articles

• Invited commentary.

  Hoover EL. Hoover EL. Ann Thorac Surg. 2007 Apr;83(4):1278. doi: 10.1016/j.athoracsur.2007.01.045. Ann Thorac Surg. 2007. PMID: 17383326 No abstract available.
• Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.

  Chang DT, Chapman C, Shen J, Su Z, Koong AC. Chang DT, et al. Am J Clin Oncol. 2009 Aug;32(4):405-10. doi: 10.1097/COC.0b013e3181917158. Am J Clin Oncol. 2009. PMID: 19415029
• Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.

  Luu TD, Gaur P, Force SD, Staley CA, Mansour KA, Miller JI Jr, Miller DL. Luu TD, et al. Ann Thorac Surg. 2008 Apr;85(4):1217-23; discussion 1223-4. doi: 10.1016/j.athoracsur.2007.11.070. Ann Thorac Surg. 2008. PMID: 18355499
• [Perioperative therapy in esophageal and stomach carcinoma].

  Stahl M, Wilke H, Meyer HJ. Stahl M, et al. Med Klin (Munich). 1996 Apr 12;91 Suppl 3:85-92. Med Klin (Munich). 1996. PMID: 8692126 Review. German. No abstract available.
• Neoadjuvant therapy for esophageal cancer: surgical considerations.

  Piraino A, Vita ML, Tessitore A, Cusumano G, Congedo MT, Margaritora S, Porziella V, Meacci E, Cesario A, Granone P. Piraino A, et al. Rays. 2006 Jan-Mar;31(1):37-45. Rays. 2006. PMID: 16999374 Review.